Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
Kellie Smith, 52, lives in Austin with her husband and child. She has multiple myeloma.
There are many ways to get smarter in this issue.
98% of people who received the customized immunotherapy responded to the one-time treatment.
Screening high-risk groups could improve the survival of patients who develop myeloma.
Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects.
People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.
Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.
African Americans are twice as likely to be diagnosed with multiple myeloma as white people, but lag in treatment gains.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
Warring Khushwinder, 59, an engineer and a member of the Sikh faith, lives in Orangevale, California. He had multiple myeloma.
Certain types of cancer treatment can lead to inadequate immune response.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
A study from the Leukemia & Lymphoma Society finds that antibody production varies widely across blood cancer types.
The monoclonal antibody reduces the risk of disease progression or death by 45%.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.